Women who use a hormone-releasing intrauterine device, or IUD, face around the same risk of breast cancer as women who take ...

During follow-up of almost 7 years, hormone-releasing IUD use conferred a 40% higher risk of breast cancer. The data showed a ...

The study found an 'unexpected' association between the use of an intrauterine system, also known as an hormonal coil, and an ...

If you have any questions, ask your doctor or pharmacist. This device is placed in your uterus by a health care provider during an in-office visit. It is left in place for up to 8 years.

On Monday, Hologic Inc (NASDAQ:HOLX) agreed to acquire Gynesonics, Inc. for approximately $350 million. Gynesonics is a ...

See related article at KEY POINTS Early pregnancy loss is common and often devastating. Adverse medical and psychological complications may be avoided with the provision of informed, compassionate ...

Iowa is under a near-total abortion ban, and Democratic challenger Lanon Baccam is trying to make it US Rep. Zach Nunn’s ...

Hormone replacement therapy will be available at no cost to menopausal women starting in January, but will pharmacies be able ...

A new study adds to the evidence on hormonal contraceptives and breast cancer. But experts stressed the overall risk remains ...

Gynesonics pioneered and launched the Sonata System, the first FDA-cleared medical device for diagnostic intrauterine imaging ...

Rural mobile programs aren’t as efficient or profitable as brick-and-mortar clinics. That’s because staff members may have to ...

Medical device manufacturer Hologic is broadening its focus on women’s health as the Marlborough-based firm has signed a ...